[PDF] Severe cisplatin-induced renal toxicity in a patient with xeroderma





Previous PDF Next PDF



Protocole National de Diagnostic et de Soins (PNDS) Xeroderma

13 sept. 2021 Xeroderma Pigmentosum. Argumentaire. Filière FIMARAD : Santé Maladies ... Xeroderma Pigmentosum (XP). ... treatment of. Décrire l'intérêt.



Dental Treatment of A Xeroderma Pigmentosum Patient Under Deep

Xeroderma pigmentosum (XP) is an autosomal recessive disorder which is characterized by hypersensitivity to ultraviolet radia- tion premature skin aging



Xeroderma pigmentosum: overview of pharmacology and novel

19 sept. 2018 The available pharmacological treatments in XP mostly target the dermal manifestations of the disease. In the present review we outline how ...



The treatment of basal cell carcinomas in a patient with xeroderma

Xeroderma pigmentosum (XP) is a rare autosomal recessive photosensitive disorder facial BCCs previously treated by surgical excision.



Pembrolizumab treatment of a patient with xeroderma pigmentosum

Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers. DOI: 10.1111/bjd.16525.



Xeroderma Pigmentosum: Gene Variants and Splice Variants

29 juil. 2021 Skin cancers should be treated according to standard therapy guidelines with surgery being the treatment of choice for invasive skin cancer.



Severe cisplatin-induced renal toxicity in a patient with xeroderma

Acute kidney injury is a well-known complication of cisplatin. Case report: We report a 42-year-old male with a long history of Xeroderma pigmentosum treated 



Unresectable and chemoresistant conjunctival squamous cell

11 avr. 2022 cell carcinoma on xeroderma pigmentosum treated by salvage radiation therapy: A case report and a review of the literature. Mané Maimouna1.



Xeroderma pigmentosum â•? bridging a gap between clinic and

Although there is no cure for XP the efficacy of oral retinoids for the prevention of new skin cancers



Xeroderma pigmentosum. Showing common skin cancers plus

24 fév. 2007 The treatment of xeroderma pigmentosum has received scant attention in the literature probably because of the rarity of the disease.